Valuation : Novartis AG

Market Cap 262B 225B 212B 193B 362B 24,925B 363B 2,515B 972B 12,698B 984B 962B 40,228B P/E 2026 *
19.5x
P/E 2027 * 16.5x
Enterprise Value 295B 254B 239B 218B 407B 28,050B 409B 2,831B 1,094B 14,290B 1,107B 1,083B 45,272B EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.73x
Free-Float
91.66%
Yield 2026 *
3.2%
Yield 2027 * 3.34%
1 day-0.13%
1 week-14.97%
Current month-9.41%
1 month-11.37%
3 months-5.68%
6 months-10.89%
Current year+1.88%
1 week 110.3
Extreme 110.3
130.86
1 month 110.3
Extreme 110.3
132.68
Current year 107.68
Extreme 107.68
132.68
1 year 96.03
Extreme 96.03
132.68
3 years 81.1
Extreme 81.1
132.68
5 years 72.84
Extreme 72.84
132.68
10 years 65.09
Extreme 65.09
132.68
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap. Importance
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.13%-14.97%+9.41%+26.71% 263B
+0.03%-3.09%+49.77%+91.69% 1,002B
-0.76%-2.95%+50.93%+66.34% 649B
+0.86%-4.13%+19.24%+68.37% 440B
-0.80%-0.43%+28.92%+35.45% 346B
-1.90%-2.72%-2.72%+7.41% 250B
-0.48%-11.65%+39.75%+50.82% 213B
-1.06%-4.23%-14.70%-57.36% 201B
-0.68%-2.65%+25.82%+91.64% 182B
-0.04%-4.27%+12.42%-18.89% 158B
Average -0.50%-4.40%+21.88%+36.22% 370.21B
Weighted average by Cap. -0.40%-3.90%+31.15%+53.76%

Financials

2026 *2027 *
Net sales 57.64B 49.6B 46.7B 42.55B 79.62B 5,485B 79.94B 554B 214B 2,794B 216B 212B 8,852B 61.32B 52.76B 49.68B 45.27B 84.7B 5,835B 85.03B 589B 228B 2,972B 230B 225B 9,417B
Net income 14.19B 12.21B 11.5B 10.48B 19.6B 1,350B 19.68B 136B 52.67B 688B 53.29B 52.13B 2,179B 15.75B 13.55B 12.76B 11.63B 21.75B 1,498B 21.84B 151B 58.45B 763B 59.13B 57.85B 2,418B
Net Debt 32.84B 28.26B 26.61B 24.25B 45.36B 3,125B 45.55B 315B 122B 1,592B 123B 121B 5,044B 27.9B 24B 22.6B 20.59B 38.53B 2,654B 38.69B 268B 104B 1,352B 105B 102B 4,284B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
09/09/26 CHF 111.66 -0.13% 4,317,913
08/09/26 CHF 111.80 -10.89% 10,430,648
07/09/26 CHF 125.46 -3.18% 3,116,102
04/09/26 CHF 129.58 -1.33% 2,616,060
03/09/26 CHF 131.32 0.00% 3,248,432
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
137.81USD
Average target price
153.34USD
Spread / Average Target
+11.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock